Fact based stock research
DENTSPLY (NasdaqGS:XRAY)


DENTSPLY stock research in summary

dentsply.com


DENTSPLY shares have a SELL rating. While they are good value, they are riskily financed, and show below average growth. We recommend selling DENTSPLY shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Supplies
Index NASDAQ 100, NASDAQ, S&P 500, D.J. US Medical Equipment
Size class XX-Large

June 8, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock



Research History: DENTSPLY

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
61
63
51
66
STOCK GROWTH RANKS
30
87
23
8
STOCK SAFETY RANKS
39
34
10
22
COMBINED STOCK RANKS
27
69
35
1

Last update of Combined Rank: 8-Jun-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is DENTSPLY in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 8-Jun-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of DENTSPLY; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
14
91
33
29
PROFIT GROWTH
5
10
10
47
STOCK RETURNS
46
54
46
21
CONSOLIDATED RANK: GROWTH
30
87
23
8

Financial reporting date of Growth Rank: 31-Mar-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of DENTSPLY.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
31
28
24
16
REFINANCING
40
43
33
47
LIQUIDITY
66
59
58
39
CONSOLIDATED RANK: SAFETY
39
34
10
22

Financial reporting date of Safety Rank: 31-Mar-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of DENTSPLY and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for DENTSPLY from June 8, 2018.